Product design and development firm Cambridge Consultants has announced the latest step in its international expansion programme. Ambuj Jain has been appointed regional leader for India – to drive the growth of the company’s drug delivery device development business in the region.
Jain has 14 years’ experience in the Indian healthcare industry – spanning drug delivery devices, pharmaceuticals and medical products. His remit at Cambridge Consultants is to develop new business opportunities in India for the company’s global drug delivery device development team.
“We have a 54-year track record as a world-class supplier of innovative product development engineering and technology consulting,” said Andrew Diston, head of global medical technology at Cambridge Consultants. “As part of our continuing growth, the appointment of Ambuj is designed to help companies in India access this expertise for their next-generation medical devices and technologies.”
From inhalers and nebulisers to auto-injectors, the Cambridge Consultants drug delivery team works with some of the world’s largest blue-chip companies as well as with some of the smallest, innovative start-ups. The team’s drug delivery device developments have been successfully launched on international markets and have gained design awards in their own right – for example, the Novartis TOBI Podhaler, Chiesi’s NEXThaler, and the Starhaler for leading Indian pharmaceutical research company Sun Pharma.
“We provide clients with an unparalleled skill set – from product design, human factors and mechanical engineering, through software, electronics and wireless communications, to life science – enabling them to trust us with their most technically and commercially challenging projects,” said Jain, who is based in Delhi.
“No matter where they are in the world, companies must embrace innovation and adopt technology if they are to stay competitive at both a domestic and global level. I am looking forward to working with a range of Indian pharmaceutical and medical device companies to help them bring innovative products to market fast.”
Having grown year on year over the past decade, Cambridge Consultants has now accelerated its expansion and is a third of the way through a four-year plan to double in size. The company is expanding its headquarters in Cambridge, UK, and moving its US office to larger premises in Boston. Last year the company also opened an office in Singapore – and held a pharma workshop in Mumbai to explore the question of whether India will become one of the world’s leading pharmaceutical countries by 2030. To request a copy of the workshop report – India: Driving world pharmaceuticals by 2030? – visit: www.cambridgeconsultants.com/2013-india-workshop-report